Philippe Mourere

Philippe Mourere is currently the CEO and President of Stilla Technologies. Prior to this, they were the Sr. Vice President Commercial & Business Development at HalioDx from July 2020 to January 2021.

Before HalioDx, Philippe was with Ultivue from March 2017 to April 2020 as the Sr. Vice President Commercial Operations. At Ultivue, they were responsible for developing the commercialization strategy and portfolio roadmaps that attracted over $40M in funding. Philippe also implemented commercial strategies in prioritized translational medicine and clinical markets within biopharma and leading cancer research centers segments. Lastly, they set up and developed all aspects of Marketing, Sales, Distribution, Business Development, Application Scientific teams and Contract Services functions while providing executive leadership across all company functions.

Philippe has extensive experience in developing and commercializing innovative technologies in the life sciences industry. Their experience will be invaluable in leading Stilla Technologies to continued success.

Some direct reports include Khaled Bahi - CFO, Etienne Fradet - VP of R&D, and Rémi Dangla - CTO, Co-Founder & Inventor.